profile-img
Clinical Lung Cancer

@ClinicalLung

Peer-reviewed journal covering clinical and translational research of lung and other thoracic cancers published by Elsevier. EIC: Antoinette Wozniak MD

calendar_today31-03-2022 17:56:19

75 Tweets

500 Followers

181 Following

Clinical Lung Cancer(@ClinicalLung) 's Twitter Profile Photo
Clinical Lung Cancer
@ClinicalLung

1 year ago

ABLATE is a multicenter, randomized phase II study assessing whether the addition of SBRT to improves outcomes for patients with newly diagnosed EGFR-mutant NSCLC.

Link to the full article: bit.ly/3dLMW0W

ABLATE is a multicenter, randomized phase II study assessing whether the addition of SBRT to #lazertinib improves outcomes for patients with newly diagnosed EGFR-mutant NSCLC. Link to the full article: bit.ly/3dLMW0W #LCSM
account_circle